Ad
related to: gsk access application
Search results
Results from the WOW.Com Content Network
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .
The Access to Medicine Index is a ranking system published biennially since 2008 by the Access to Medicine ... GSK plc (4.06) 1 1: 1: 1 Johnson & Johnson (4.03) 2 3: ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
The site was the Official Laboratory Services Provider for the 2012 Summer Olympics; every medallist and 50% of competitors were tested by GSK there. 150 scientists from King's College London and the World Anti-Doping Agency would be there, to take around 6,000 samples. 240 prohibited substances would be tested for, with about 400 samples per ...
GTK Scene Graph Kit (GSK) is the rendering and scene graph API for GTK introduced with version 3.90. GSK lies between the graphical control elements (widgets) and the rendering. GSK lies between the graphical control elements (widgets) and the rendering.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
GSK may refer to: GSK plc, formerly GlaxoSmithKline, a multinational pharmaceutical corporation; Galatasaray S.K., a Turkish sports club based in Istanbul; Glycogen synthase kinase; Golden State Killer, a California serial rapist and murderer; GTK Scene Graph Kit, a rendering pipeline
The company was created as a joint venture by GSK and Pfizer in November 2009, with both companies transferring their HIV assets to the new company. [1] In 2012, Shionogi joined the company. As of December 2023, 76.5% of the company is owned by GSK, 13.5% by Pfizer and 10% by Shionogi. [2]
Ad
related to: gsk access application